Neurovascular Associates Of Abington - Medicare Mental Health Clinic in Abington, PA

Neurovascular Associates Of Abington is a medicare enrolled mental health clinic (Psychiatry & Neurology - Neurology) in Abington, Pennsylvania. The current practice location for Neurovascular Associates Of Abington is 1200 Old York Rd, 1 Widener, Abington, Pennsylvania. For appointments, you can reach them via phone at (215) 481-3145. The mailing address for Neurovascular Associates Of Abington is Po Box 826594, Philadelphia, Pennsylvania and phone number is (215) 657-5886.

Neurovascular Associates Of Abington is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1649415639. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (215) 481-3145.

Contact Information

Neurovascular Associates Of Abington
1200 Old York Rd
1 Widener
Abington
PA 19001-3720
(215) 481-3145
(215) 481-5971

Mental Health Clinic Profile

Full NameNeurovascular Associates Of Abington
SpecialityPsychiatry & Neurology
Location1200 Old York Rd, Abington, Pennsylvania
Authorized Official Name and PositionMichael Walsh (CFO)
Authorized Official Contact2154812000
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Neurovascular Associates Of Abington
Po Box 826594
Philadelphia
PA 19182-6594

Ph: (215) 657-5886
Neurovascular Associates Of Abington
1200 Old York Rd
1 Widener
Abington
PA 19001-3720

Ph: (215) 481-3145

NPI Details:

NPI Number1649415639
Provider Enumeration Date12/05/2008
Last Update Date01/04/2024
Certification Date01/04/2024

Medicare PECOS Information:

Medicare PECOS PAC ID3274437736
Medicare Enrollment IDO20090226000505

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Neurovascular Associates Of Abington such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1649415639NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084N0400XPsychiatry & Neurology - Neurology (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Neurovascular Associates Of Abington acts as a billing entity for following providers:
Provider NameLarami G Mackenzie
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1609921519
PECOS PAC ID: 8426109844
Enrollment ID: I20090625000186

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameOsman S Kozak
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1003861733
PECOS PAC ID: 0143247338
Enrollment ID: I20090923000556

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameHana Choe
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1336301571
PECOS PAC ID: 8628253416
Enrollment ID: I20110420000468

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NamePatricia A Bussinger
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1033575287
PECOS PAC ID: 7810293891
Enrollment ID: I20160317001221

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameNabeel A Herial
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1477866101
PECOS PAC ID: 6103043864
Enrollment ID: I20170630002000

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameGregory Rother
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1578075768
PECOS PAC ID: 9234497876
Enrollment ID: I20180103001014

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameLisa R Griffin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295246189
PECOS PAC ID: 0446519250
Enrollment ID: I20180123002469

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameSherry A Kessler
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1558833541
PECOS PAC ID: 5991042723
Enrollment ID: I20190131002189

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameSteven Eric Blasek
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154834596
PECOS PAC ID: 1456610534
Enrollment ID: I20191118001679

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameKumud Sharma
Provider TypePractitioner - Neurology
Provider IdentifiersNPI Number: 1861808685
PECOS PAC ID: 4789937459
Enrollment ID: I20200915003626

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameJennifer L Sweeney
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679103634
PECOS PAC ID: 6709205602
Enrollment ID: I20200925001800

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameKristi L Piller
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1558757609
PECOS PAC ID: 0244591691
Enrollment ID: I20210715000143

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

Provider NameAndriy Bashta
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1003570912
PECOS PAC ID: 3274923198
Enrollment ID: I20211209000049

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more Medical News

› Verified 2 days ago

News Archive

New mobile program increases parents' adherence to safe sleep practices for infants

Mother's latest little helper is already in her pocket: A new educational intervention delivered in the form of texts and emails has been found to increase adherence to safe sleep practices for infants, concluded researchers at the Yale, University of Virginia, and Boston University schools of medicine in a joint study published July 25 in the Journal of the American Medical Association.

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

Biomarkers can increase success rate of clinical trials for breast cancer drugs by almost 50%

Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.

Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds

Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

Read more News

› Verified 2 days ago

Psychiatry & Neurology in Abington, PA

Child And Family Focus, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 900 Highland Ave, Abington, PA 19001
Phone: 215-957-9771    
Rapha Counseling Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1432 Edgewood Ave, Abington, PA 19001
Phone: 215-908-7551    
Feeling Better Psychotherapy Associates, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1564 Edge Hill Rd, Abington, PA 19001
Phone: 215-657-4200    
Cmc Of Pa Pc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1021 Old York Rd Ste 301, Abington, PA 19001
Phone: 215-254-6000    
Element Wellness Services Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2244 Hillthorpe Ave, Abington, PA 19001
Phone: 215-327-7122    
Collaborative Care, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1369 Old York Rd, Abington, PA 19001
Phone: 215-884-1776    Fax: 215-884-0171
The Sensitive Path, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2223 Florey Ln, Abington, PA 19001
Phone: 267-567-9628    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.